Oncothyreon announces March 10th webcast of fourth quarter and full year financial results conference call
March 19, 2008 – 10:33 pmBELLEVUE, WA, March 7 /PRNewswire-FirstCall/ - Oncothyreon Inc. (the
“Company”) (Nasdaq: ONTY) (TSX:ONY), a biotechnology company specializing
in the development of innovative therapeutic products for the treatment of
cancer, today announced that it intends to release its fourth quarter and
full year 2007 financial results on Monday, March 10, 2008 after the close
of the U.S. and Canadian markets. Following the release, Oncothyreon’s
management expects to discuss these financial results and give a general
business update in a conference call at 4:30 p.m. EST.
The discussion is planned for a live webcast and can be accessed at
http://www.oncothyreon.com. It is expected that the archive of the webcast will be
available approximately one hour after completion of the discussion and
will be posted on the Oncothyreon website for 30 days.
About Oncothyreon
Oncothyreon is a biotechnology company specializing in the development
of innovative therapeutic products for the treatment of cancer.
Oncothyreon’s goal is to develop and commercialize novel synthetic vaccines
and targeted small molecules that have the potential to improve the lives
and outcomes of cancer patients. For more information, visit
http://www.oncothyreon.com.
See Also
- Research Shows Alcohol Can Benefit the Hearts of New Drinkers
- Susan G. Komen for the Cure(R) Announces Global Promise Fund to Help Women Worldwide
- Compelling New Fashion Designer Expands into Chicago/Midwest Market
- Atherotech to Exhibit the VAP Test (R) at ACC 2008 Meeting in Chicago
Via: Healthcare
Related articles:
- ADVENTRX Pharmaceuticals to Report Fourth Quarter and Year End 2007 Results
- Carriage Services Announces Fourth Quarter and Year-End Earnings Release and Conference Call Schedule
- Genoptix Announces Participation at Cowen and Company 28th Annual Health Care Conference
- Champions Biotechnology, Inc. Reports Two Cents per Share Earnings for Three Quarters Ended January 31, 2008
- Halozyme Therapeutics to Hold Pipeline Update Conference Call on March 14
| Note: |
| This site and its services, including the information above, are for informational purposes only and are not a substitute for professional medical or health advice, examination, diagnosis, or treatment. Always seek the advice of your physician or other qualified health professional before starting any new treatment, making any changes to existing treatment, or altering in any way your current exercise or diet regimen. Do not delay seeking or disregard medical advice based on information on this site. |
